Effect of Social Media Support and Financial Incentives on PrEP Adherence

Pre-Exposure Prophylaxis Clinical Trial

Official title:

The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03078153
• Other study ID #: 111642
• Secondary ID: 1P30AI117970
• Status: Completed
• Phase: N/A
• Start date: April 1, 2017
• Est. completion date: December 15, 2020

Study information

• Verified date: February 2021
• Source: George Washington University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if social media support and financial incentives improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24 living in the Washington, DC area who are at high risk for HIV acquisition.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 57
• Est. completion date: December 15, 2020
• Est. primary completion date: December 15, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 24 Years

Eligibility

Inclusion Criteria:

• Male assigned at birth (regardless of current gender identity)

• Age 18-24

• Black/African American, Latino or Asian

• HIV negative

• History of unprotected anal sex with a man in the last 6 months

• Living within the DC metropolitan statistical area and anticipate remaining within the DC area for the next 6 months

• Not enrolled in any other HIV prevention trial

• Interested in taking PrEP

• Not a current PrEP user and have not taken PrEP in the last 30 days

• Able to provide informed consent

Exclusion Criteria:

• Female sex at birth

• Age younger than 18 or older than 24

• Caucasian

• HIV positive

• Actively taking PrEP or having taken PrEP within 30 days of enrollment

• Chronic hepatitis B infection

• Known renal insufficiency

• On probation or parole

• Any other conditions that the Principal Investigator may consider a contraindication to enrolling in the study

Related Conditions & MeSH terms

• Pre-Exposure Prophylaxis

Intervention

Behavioral:
• Financial Incentive
Participants will receive a $50 gift card at 3- and 6- month follow-up visits.
• Social Media Group
Participants will be invited to a study Facebook group which will have links to PrEP information and provide a forum for participants to ask questions and communicate their experience with PrEP

Locations

Country	Name	City	State
United States	The GW Medical Faculty Associates	Washington	District of Columbia

Sponsors (3)

Lead Sponsor	Collaborator
George Washington University	Gilead Sciences, National Institute of Allergy and Infectious Diseases (NIAID)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adherence To Truvada	Level of Truvada drug levels inside red blood cells (performed by dried blood spots)	6 months
Secondary	New Cases of HIV	Number of reactive HIV rapid and 4th generation tests	6 months
Secondary	Incidence of STIs	Positive RPR, oropharyngeal/rectal/penile chlamydia and gonorrhea during study	6 months